Skip to content

Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis

Linked Color Imaging (LCI) Versus White Light for the Detection of Colorectal Dysplasia in Ulcerative Colitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02772406
Enrollment
60
Registered
2016-05-13
Start date
2016-04-30
Completion date
2016-12-31
Last updated
2016-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

ulcerative colitis, colonoscopy, Dysplasia, Diagnosis

Brief summary

The purpose of the study is to determine whether a new colonoscopic viewing technique called Linked color imaging(LCI) helps endoscopists detect more dysplasia lesions in ulcerative colitis patients than conventional colonoscopy using white light alone.

Detailed description

Patients with longstanding IBD have increased risk of colorectal cancer (CRC) compared to the general population. The association between duration of the disease and development of CRC is the rationale for endoscopic surveillance. Colonoscopic surveillance of ulcerative colitis patients has been shown to reduce the risk of colorectal cancer and allow detection at an earlier stage, but even with meticulous examination, some precancerous lesions or cancers are missed. The newly developed LCI system (FUJIFILM Co.) creates clear and bright endoscopic images by using short-wavelength narrow-band laser light combined with white laser light on the basis of BLI technology. LCI makes red areas appear redder and white areas appear whiter. Thus, it is easier to recognize a slight difference in color of the mucosa. This is a study to determine if using Linked color imaging (LCI) of the colon, rather than the usual white light on the colon, will improve the detection of more dysplasia lesions in ulcerative colitis.

Interventions

Sponsors

Affiliated Hospital to Academy of Military Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

patients with ulcerative colitis who meet surveillance criteria

Exclusion criteria

pregnant patients,unable or unwilling to give informed consent,patients with severe active colitis who would be unsafe to endoscope

Design outcomes

Primary

MeasureTime frame
The number of Colorectal Dysplasia detected by LCI6 months

Secondary

MeasureTime frame
The endoscopic scores with LCI6 months

Countries

China

Contacts

Primary ContactMin Min, M.D.,Ph.D.
minmin823@sina.com+86-010-66947473
Backup ContactXiaotian Sun, M.D.,Ph.D.
xiaotian-sun@hotmail.com+86-010-66947473

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026